TTP is characterized by microvascular thrombosis associated with markedly decreased ADAMTS13 activity due to mutation of ADAMTS13 gene (hereditary) or due to antibody against ADAMTS13 (acquired). The gene discussed is ADAMTS13; the disease is thrombotic thrombocytopenic purpura.